Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aculys, Aqualung, Boehringer Ingelheim, Cytoimmune, Evotec, G1, Gilead, Immix, Inmune, Monte Rosa, Neurelis, Opiant, Regenerx, Siga, Spago, Yeda.